Company intelligence / Profile preview

Ascend Technology Ventures

Ramat Gan, Israel

Ownership: Private
Development stage: Other

Overview

Ascend Technology Ventures was an Israeli venture capital firm founded in 1999 that specialized in early-stage investments in high-growth technology sectors, including life sciences, medical devices, and information technology. Based in Ramat Gan, the firm managed a $100 million fund and provided capital and strategic guidance to startups in Israel and the United States. Its healthcare portfolio included notable companies such as Can-Fite BioPharma and Glucon, focusing on innovative medical technologies and biotechnology. The firm was active during the early 2000s tech expansion but is currently considered inactive or dissolved. It is distinct from more recent biotech entities like Ascend Advanced Therapies, a gene therapy CDMO.

Industry: Investors

Beyond the preview

Go deeper on Ascend Technology Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ascend Technology Ventures.

Explore the full profile